An advisory committee to the US Food and Drug Administration (FDA) voted 8-6 with one abstention on Thursday to recommend that two peptides BPC-157 to treat ulcerative colitis and KPV for wound treatment and inflammatory conditions be added to the list of drugs eligible for bulk compounding, known as the 503A Bulks List
Working great Customer service is wonderful and quick response
Fusion for Lumbar Stenosis Some had surgery, some did not A May 2022 study ( 2 ) followed a group of patients diagnosed with lumbar spinal stenosis
Under professional direction, peptide treatment can provide a very focused method to maximize general well-being, lower indications of aging, and improve skin health
[PubMed] [Google Scholar] Simon M., Montzin M., Guerrin M., Durieux J.J., Serre G